Luliked Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin such as tinea corporis, tinea cruris, and tinea pedis. Luliconazole exhibits broad-spectrum antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation ensures effective penetration into the stratum corneum, providing targeted action against dermatophytes and yeasts including Candida species. Luliked Cream is typically applied once daily to the affected area after cleansing and drying the skin, with the duration of therapy depending on the type and severity of infection, generally ranging from one to four weeks. It is well tolerated with minimal adverse effects, the most common being mild local irritation, burning, or itching at the application site. Luliked Cream should be used with caution in patients with known hypersensitivity to luliconazole or any of the cream’s excipients. It is intended for external use only and should not be applied to mucous membranes or broken skin. Proper adherence to the prescribed regimen is essential to ensure complete resolution of infection and to prevent recurrence.